• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间质和局灶性心脏纤维化的生物线模型

Biowire Model of Interstitial and Focal Cardiac Fibrosis.

作者信息

Wang Erika Yan, Rafatian Naimeh, Zhao Yimu, Lee Angela, Lai Benjamin Fook Lun, Lu Rick Xingze, Jekic Danica, Davenport Huyer Locke, Knee-Walden Ericka J, Bhattacharya Shoumo, Backx Peter H, Radisic Milica

机构信息

Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.

Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada.

出版信息

ACS Cent Sci. 2019 Jul 24;5(7):1146-1158. doi: 10.1021/acscentsci.9b00052. Epub 2019 Jun 4.

DOI:10.1021/acscentsci.9b00052
PMID:31403068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6661857/
Abstract

Myocardial fibrosis is a severe global health problem due to its prevalence in all forms of cardiac diseases and direct role in causing heart failure. The discovery of efficient antifibrotic compounds has been hampered due to the lack of a physiologically relevant disease model. Herein, we present a disease model of human myocardial fibrosis and use it to establish a compound screening system. In the Biowire II platform, cardiac tissues are suspended between a pair of poly(octamethylene maleate (anhydride) citrate) (POMaC) wires. Noninvasive functional readouts are realized on the basis of the deflection of the intrinsically fluorescent polymer. The disease model is constructed to recapitulate contractile, biomechanical, and electrophysiological complexities of fibrotic myocardium. Additionally, we constructed a heteropolar integrated model with fibrotic and healthy cardiac tissues coupled together. The integrated model captures the regional heterogeneity of scar lesion, border zone, and adjacent healthy myocardium. Finally, we demonstrate the utility of the system for the evaluation of antifibrotic compounds. The high-fidelity model system combined with convenient functional readouts could potentially facilitate the development of precision medicine strategies for cardiac fibrosis modeling and establish a pipeline for preclinical compound screening.

摘要

心肌纤维化是一个严重的全球健康问题,因为它在所有形式的心脏病中都普遍存在,并且在导致心力衰竭方面具有直接作用。由于缺乏生理相关的疾病模型,高效抗纤维化化合物的发现受到了阻碍。在此,我们提出了一种人类心肌纤维化疾病模型,并利用它建立了一个化合物筛选系统。在Biowire II平台中,心脏组织悬浮在一对聚(马来酸(酐)柠檬酸辛二酯)(POMaC)线之间。基于本征荧光聚合物的偏转实现了非侵入性功能读数。构建该疾病模型以概括纤维化心肌的收缩、生物力学和电生理复杂性。此外,我们构建了一个将纤维化和健康心脏组织耦合在一起的异极集成模型。该集成模型捕捉了瘢痕病变、边界区和相邻健康心肌的区域异质性。最后,我们展示了该系统在评估抗纤维化化合物方面的实用性。高保真模型系统与便捷的功能读数相结合,可能有助于开发用于心脏纤维化建模的精准医学策略,并建立一个临床前化合物筛选管道。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c00a/6661857/b4d5d009dc3e/oc-2019-00052p_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c00a/6661857/f3e9d2a6abbb/oc-2019-00052p_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c00a/6661857/c6ee9183558d/oc-2019-00052p_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c00a/6661857/bf60ed4185af/oc-2019-00052p_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c00a/6661857/41f489193945/oc-2019-00052p_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c00a/6661857/4d02a814e003/oc-2019-00052p_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c00a/6661857/b4d5d009dc3e/oc-2019-00052p_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c00a/6661857/f3e9d2a6abbb/oc-2019-00052p_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c00a/6661857/c6ee9183558d/oc-2019-00052p_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c00a/6661857/bf60ed4185af/oc-2019-00052p_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c00a/6661857/41f489193945/oc-2019-00052p_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c00a/6661857/4d02a814e003/oc-2019-00052p_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c00a/6661857/b4d5d009dc3e/oc-2019-00052p_0006.jpg

相似文献

1
Biowire Model of Interstitial and Focal Cardiac Fibrosis.间质和局灶性心脏纤维化的生物线模型
ACS Cent Sci. 2019 Jul 24;5(7):1146-1158. doi: 10.1021/acscentsci.9b00052. Epub 2019 Jun 4.
2
Design and Fabrication of Biological Wires for Cardiac Fibrosis Disease Modeling.生物线材设计与制作及其在心脏纤维化疾病建模中的应用。
Methods Mol Biol. 2022;2485:175-190. doi: 10.1007/978-1-0716-2261-2_12.
3
3D Printability Assessment of Poly(octamethylene maleate (anhydride) citrate) and Poly(ethylene glycol) Diacrylate Copolymers for Biomedical Applications.用于生物医学应用的聚(马来酸(酐)柠檬酸辛二醇酯)与聚乙二醇二丙烯酸酯共聚物的3D打印适性评估
ACS Appl Polym Mater. 2022 Aug 12;4(8):5457-5470. doi: 10.1021/acsapm.2c00531. Epub 2022 Jul 7.
4
Oncofetal Protein CRIPTO Is Involved in Wound Healing and Fibrogenesis in the Regenerating Liver and Is Associated with the Initial Stages of Cardiac Fibrosis.癌胚蛋白 CRIPTO 参与再生肝脏中的伤口愈合和纤维化,并与心脏纤维化的初始阶段相关。
Cells. 2021 Nov 26;10(12):3325. doi: 10.3390/cells10123325.
5
Biomimetic Cardiac Fibrotic Model for Antifibrotic Drug Screening.用于抗纤维化药物筛选的仿生心脏纤维化模型
Tissue Eng Part C Methods. 2023 Dec;29(12):558-571. doi: 10.1089/ten.TEC.2023.0089. Epub 2023 Nov 6.
6
Comparative transcriptomic analysis validates iPSC derived in-vitro progressive fibrosis model as a screening tool for drug discovery and development in systemic sclerosis.比较转录组学分析验证了 iPSC 衍生的体外进行性纤维化模型作为系统性硬化症药物发现和开发的筛选工具。
Sci Rep. 2024 Oct 18;14(1):24428. doi: 10.1038/s41598-024-74610-2.
7
Focal But Not Diffuse Myocardial Fibrosis Burden Quantification Using Cardiac Magnetic Resonance Imaging Predicts Left Ventricular Reverse Modeling Following Cardiac Resynchronization Therapy.使用心脏磁共振成像进行局灶性而非弥漫性心肌纤维化负担定量可预测心脏再同步治疗后的左心室逆向重构。
J Cardiovasc Electrophysiol. 2016 Feb;27(2):203-9. doi: 10.1111/jce.12855. Epub 2015 Dec 17.
8
Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration.心肌梗死中的心脏纤维化——从修复、重塑到再生
Cell Tissue Res. 2016 Sep;365(3):563-81. doi: 10.1007/s00441-016-2431-9. Epub 2016 Jun 21.
9
Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction.天然化合物文库筛选鉴定出治疗心肌纤维化和舒张功能障碍的新分子。
Circulation. 2020 Mar 3;141(9):751-767. doi: 10.1161/CIRCULATIONAHA.119.042559. Epub 2020 Jan 17.
10
Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.用于评估心肌活力的正电子发射断层扫描:一项基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(16):1-167. Epub 2005 Oct 1.

引用本文的文献

1
Cardiac Tissue Bioprinting: Integrating Structure and Functions Through Biomimetic Design, Bioinks, and Stimulation.心脏组织生物打印:通过仿生设计、生物墨水和刺激整合结构与功能
Gels. 2025 Jul 31;11(8):593. doi: 10.3390/gels11080593.
2
Cardiac fibroblast-mediated ECM remodeling regulates maturation in an in vitro 3D engineered cardiac tissue.心脏成纤维细胞介导的细胞外基质重塑在体外三维工程化心脏组织中调节成熟过程。
J Tissue Eng. 2025 Aug 21;16:20417314251356321. doi: 10.1177/20417314251356321. eCollection 2025 Jan-Dec.
3
A dermis-on-a-chip model for compound screening.

本文引用的文献

1
Fibroblasts Slow Conduction Velocity in a Reconstituted Tissue Model of Fibrotic Cardiomyopathy.在纤维化心肌病的重组组织模型中,成纤维细胞减缓传导速度。
ACS Biomater Sci Eng. 2017 Nov 13;3(11):3022-3028. doi: 10.1021/acsbiomaterials.6b00576. Epub 2016 Oct 18.
2
A Multimaterial Microphysiological Platform Enabled by Rapid Casting of Elastic Microwires.一种基于弹性微丝快速铸造的多材料微生理平台。
Adv Healthc Mater. 2019 Mar;8(5):e1801187. doi: 10.1002/adhm.201801187. Epub 2019 Feb 9.
3
A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling.
用于化合物筛选的芯片上真皮模型。
Mater Today Bio. 2025 Jul 18;34:102111. doi: 10.1016/j.mtbio.2025.102111. eCollection 2025 Oct.
4
The mechanobiology of fibroblast activation in disease.疾病中成纤维细胞激活的力学生物学
APL Bioeng. 2025 Jun 18;9(2):021505. doi: 10.1063/5.0272393. eCollection 2025 Jun.
5
Engineering a controlled cardiac multilineage co-differentiation process using statistical design of experiments.利用实验的统计设计构建可控的心脏多谱系共分化过程。
Stem Cell Res Ther. 2025 Jun 2;16(1):273. doi: 10.1186/s13287-025-04408-0.
6
In Vitro Modeling of Interorgan Crosstalk: Multi-Organ-on-a-Chip for Studying Cardiovascular-Kidney-Metabolic Syndrome.器官间串扰的体外建模:用于研究心血管-肾脏-代谢综合征的多器官芯片
Circ Res. 2025 May 23;136(11):1476-1493. doi: 10.1161/CIRCRESAHA.125.325497. Epub 2025 May 22.
7
Suspended Tissue Open Microfluidic Patterning (STOMP).悬浮组织开放式微流控图案化技术(STOMP)
Adv Sci (Weinh). 2025 Apr 29:e2501148. doi: 10.1002/advs.202501148.
8
Dressed in Collagen: 2D and 3D Cardiac Fibrosis Models.身披胶原蛋白:二维和三维心脏纤维化模型
Int J Mol Sci. 2025 Mar 26;26(7):3038. doi: 10.3390/ijms26073038.
9
Heart-on-a-chip: a revolutionary organ-on-chip platform for cardiovascular disease modeling.芯片上的心脏:用于心血管疾病建模的革命性芯片器官平台。
J Transl Med. 2025 Jan 30;23(1):132. doi: 10.1186/s12967-024-05986-y.
10
A microfluidic coculture model for mapping signaling perturbations and precise drug screening against macrophage-mediated dynamic myocardial injury.一种用于绘制信号扰动图谱以及针对巨噬细胞介导的动态心肌损伤进行精确药物筛选的微流控共培养模型。
Acta Pharm Sin B. 2024 Dec;14(12):5393-5406. doi: 10.1016/j.apsb.2024.11.004. Epub 2024 Nov 13.
用于生成室特异性心脏组织和疾病建模的平台。
Cell. 2019 Feb 7;176(4):913-927.e18. doi: 10.1016/j.cell.2018.11.042. Epub 2019 Jan 24.
4
Cardiovascular disease models: A game changing paradigm in drug discovery and screening.心血管疾病模型:药物发现和筛选的变革性范式。
Biomaterials. 2019 Apr;198:3-26. doi: 10.1016/j.biomaterials.2018.09.036. Epub 2018 Oct 1.
5
The correlation of TGFβ1 gene polymorphisms with congenital heart disease susceptibility.TGFβ1 基因多态性与先天性心脏病易感性的相关性。
Gene. 2019 Feb 20;686:160-163. doi: 10.1016/j.gene.2018.10.034. Epub 2018 Oct 12.
6
Extracellular Interactions between Fibulins and Transforming Growth Factor (TGF)-β in Physiological and Pathological Conditions.纤连蛋白与转化生长因子-β在生理和病理条件下的细胞外相互作用。
Int J Mol Sci. 2018 Sep 17;19(9):2787. doi: 10.3390/ijms19092787.
7
Fibrotic microtissue array to predict anti-fibrosis drug efficacy.纤维化微组织阵列预测抗纤维化药物疗效。
Nat Commun. 2018 May 25;9(1):2066. doi: 10.1038/s41467-018-04336-z.
8
Modeling the Electrophysiological Properties of the Infarct Border Zone.模拟梗死边缘区的电生理特性。
Front Physiol. 2018 Apr 9;9:356. doi: 10.3389/fphys.2018.00356. eCollection 2018.
9
Advanced maturation of human cardiac tissue grown from pluripotent stem cells.多能干细胞来源的人心肌组织的高级成熟。
Nature. 2018 Apr;556(7700):239-243. doi: 10.1038/s41586-018-0016-3. Epub 2018 Apr 4.
10
Engineered Microenvironments for Maturation of Stem Cell Derived Cardiac Myocytes.用于干细胞来源的心肌细胞成熟的工程化微环境。
Theranostics. 2018 Jan 1;8(1):124-140. doi: 10.7150/thno.19441. eCollection 2018.